The promise of precision medicine requires leveraging deep biological knowledge to tailor medical decisions and treatments to individual patients in a data-driven manner. To achieve this promise and promote the understanding of disease mechanisms and treatment based on innovative analyses, it requires applying specialized state-of-the-art computational tools.
These tools must be able to integrate high-throughput biological data that span intermediate molecular and cellular phenotypes underlying disease, as well as integrate and interpret the large volumes of data being generated.
Our AI-enabled platform integrates complex disease traits with genetic, clinical, and biomarker datasets to map the underlying biological pathways driving weight gain and treatment response.
The platform is then able to mechanistically tie in clinical phenotypes and medical outcomes to support applications in personalized risk predictions, intermediate phenotype predictions, further mechanistic disease understanding, and therapeutic response.
By translating these complexities into actionable insights, the platform enables a scalable shift toward systematic precision obesity care and empowers the delivery of the right intervention to the right patient, at the right time.
Application in precision obesity medicine
The MyPhenome® Test is the first and only genetic test designed to guide precision obesity medicine therapeutic approaches, including lifestyle, medications, and procedures.
MyPhenome® Test
By analyzing traits that influence appetite and energy balance, MyPhenome® Test identifies a patient’s root-cause (phenotype), and informs which therapeutic pathway will work best based on peer-reviewed clinical studies.
Through ongoing research and real-world deployments, the platform continues to demonstrate its ability to stratify patients, predict therapeutic pathways, and support more effective, scalable outcomes across the continuum of care.
